Myriad Genetics CTO files initial insider report

MYRIAD GENETICS INC filed an initial ownership report for Raj Jampa, who serves as Chief Technology Officer.

Accepted by SEC EDGAR 06/02/2026 - 04:14 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

MYRIAD GENETICS INC filed an initial ownership report for Raj Jampa, who serves as Chief Technology Officer. This Form 3 filing lists him as an officer but does not show any stock or option transactions, so it simply establishes his status as an insider for future reporting.

Key Terms

Chief Technology Officer, reportingPersons, derivativeTransactionCount

3 terms

Chief Technology Officer financial

""officer_title": "Chief Technology Officer""

The chief technology officer is the senior executive who sets a company's technology vision and oversees development, engineering, and technical operations—think of them as the lead architect and head mechanic who decides what tools the business builds and how they run. Their choices affect product direction, cost structure, cybersecurity and scalability, so investors watch the CTO to gauge a company’s ability to innovate, compete and manage technical risk.

reportingPersons financial

""reportingPersons": [ { "name": "Jampa Raj""

derivativeTransactionCount financial

""derivativeTransactionCount": 0"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Raj Jampa's Form 3 filing for MYGN indicate?

The Form 3 filing shows that Raj Jampa is an officer of MYRIAD GENETICS INC, serving as Chief Technology Officer. It is an initial ownership report and does not list any stock purchases, sales, or option exercises.

Does the MYGN Form 3 for Raj Jampa show any share transactions?

No, the Form 3 for Raj Jampa reports zero buy, sell, or derivative transactions. All transaction counts and share amounts in the summary fields are zero, so it only records his insider status, not any trading activity.

What insider role does Raj Jampa hold at MYRIAD GENETICS (MYGN)?

Raj Jampa is identified as an officer of MYRIAD GENETICS INC with the title Chief Technology Officer. This role means his future trades in company securities must be reported on Forms 4 or 5 under insider reporting rules.

Are there any derivative securities reported for Raj Jampa at MYGN?

The filing’s derivativeSummary is empty and derivative-related counts in the transaction summary are zero. This means no options, warrants, or other derivative securities are reported for Raj Jampa in this initial Form 3 submission.

What is the net buy/sell direction in Raj Jampa's MYGN Form 3?

The transaction summary shows a netBuySellDirection of "neutral" with zero net shares. This reflects that no purchases, sales, or other reportable transactions were included, only the designation of Raj Jampa as an insider officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Jampa Raj

(Last) (First) (Middle)

322 NORTH 2200 WEST

(Street)

SALT LAKE CITY UTAH 84116

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2026

3. Issuer Name and Ticker or Trading Symbol
MYRIAD GENETICS INC [ MYGN ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	By: Justin Hunter For: Raj Jampa	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)